Health impact assessment of air pollution in megacity of Tehran, Iran
Tóm tắt
The aims of the present study were to provide quantitative data on the impact of air pollution on the health of people living in Tehran city, the most populated city of Iran. The approach proposed by the World Health Organization (WHO) was applied using the AirQ 2.2.3 software developed by the WHO European Centre for Environment and Health, Bilthoven Division. Concentrations of ozone, nitrogen dioxide, sulfur dioxide and particulate matter of aerodynamic diameter ≤ 10 μm (PM10) were used to assess human exposure and health impacts in terms of attributable proportion of the health outcome, annual number of excess cases of mortality for all causes, and cardiovascular and respiratory diseases. The annual average of PM10, SO2, NO2 and O3 in Tehran were 90.58, 89.16, 85 and 68.82 μg/m3, respectively. Considering short-term effects, PM10 had the highest health impact on the 8,700,000 inhabitants of Tehran city, causing an excess of total mortality of 2194 out of 47284 in a year. Sulfur dioxide, nitrogen dioxide and ozone caused about, respectively, 1458, 1050 and 819 excess cases of total mortality. Results indicate that the magnitude of the health impact estimated for the city of Tehran underscores the need for urgent action to reduce the health burden of air pollution.
Từ khóa
Tài liệu tham khảo
Ciocco A, Thompson DJ: A follow-up of Donora ten years after: methodology and findings. Am J Public Health Nations Health. 1961, 51: 155-164. 10.2105/AJPH.51.2.155.
Nemery B, Hoet PH, Nemmar A: The Meuse Valley fog of 1930: an air pollution disaster. Lancet. 2001, 357: 704-708. 10.1016/S0140-6736(00)04135-0.
Brunekreef B, Holgate ST: Air pollution and health. Lancet. 2002, 360: 1233-1242. 10.1016/S0140-6736(02)11274-8.
Delfino RJ, Becklake MR, Hanley JA: The relationship of urgent hospital admissions for respiratory illnesses to photochemical air pollution levels in Montreal. Environ Res. 1994, 67: 1-19. 10.1006/enrs.1994.1061.
Downs SH, Schindler C, Liu LJ, Keidel D, Bayer-Oglesby L, Brutsche MH, Gerbase MW, Keller R, Kunzli N, Leuenberger P, Probst-Hensch NM, Tschopp JM, Zellweger JP, Rochat T, Schwartz J, Ackermann-Liebrich U: Reduced exposure to PM10 and attenuated age-related decline in lung function. N Engl J Med. 2007, 357: 2338-2347. 10.1056/NEJMoa073625.
Gauderman WJ, Vora H, McConnell R, Berhane K, Gilliland F, Thomas D, Lurmann F, Avol E, Kunzli N, Jerrett M, Peters J: Effect of exposure to traffic on lung development from 10 to 18 years of age: a cohort study. Lancet. 2007, 369: 571-577. 10.1016/S0140-6736(07)60037-3.
Ghorbanli M, Bakand Z, Bakhshi khaniki G, Bakand S: Air pollution effects on the activity of antioxidant enzymes in Nerium Oleander and Robinia Pseudo Acacia plants in Tehran. Iran. J Environ Health Sci Eng. 2007, 4: 157-162.
Hosseinpoor AR, Forouzanfar MH, Yunesian M, Asgharic F, Holakouie K, Farhoodd D: Environ Res. 2005, 99: 126-131. 10.1016/j.envres.2004.12.004.
Jerrett M, Shankardass K, Berhane K, Gauderman WJ, Kunzli N, Avol E, Gilliland F, Lurmann F, Molitor JN, Molitor JT, Thomas DC, Peters J, McConnell R: Traffic-related air pollution and asthma onset in children: a prospective cohort study with individual exposure measurement. Environ Health Perspect. 2008, 116: 1433-1438. 10.1289/ehp.10968.
Kunzli N, Jerrett M, Mack WJ, Beckerman B, LaBree L, Gilliland F, Thomas D, Peters J, Hodis HN: Ambient air pollution and atherosclerosis in Los Angeles. Environ Health Perspect. 2005, 113: 201-206.
Miller KA, Siscovick DS, Sheppard L, Shepherd K, Sullivan JH, Anderson GL, Kaufman JD: Long-term exposure to air pollution and incidence of cardiovascular events in women. N Engl J Med. 2007, 356: 447-458. 10.1056/NEJMoa054409.
Pope CA, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, Thurston GD: Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA. 2002, 287: 1132-1141. 10.1001/jama.287.9.1132.
Schwartz J, Morris R: Air pollution and hospital admissions for cardiovascular disease in Detroit Michigan. Am J Epidemiol. 1995, 142: 23-35.
USEPA: Air Quality Criteria for Particulate Matter. Final Report. 1996, Washington, DC: US Environmental Protection Agency, EPA 600/P-95/001
Fattore E, Paiano V, Borgini A, Tittarelli A, Bertoldi M, Crosignani P, Fanelli R: Human health risk in relation to air quality in two municipalities in an industrialized area of Northern Italy. Environ Res. 2011, 111: 1321-1327. 10.1016/j.envres.2011.06.012.
SCI: Statistic Center of Iran. 2011, Available at: http://www.amar.org.ir
WHO: Urban outdoor air pollution database. 2011, Geneva, Switzerland: August 2011 Department of Public Health and Environment, World Health Organization, Available at: http://www.who.int/phe
Krzyzanowski M: Methods for assessing the extent of exposure and effects of air pollution. Occup Environ Med. 1997, 54: 145-151. 10.1136/oem.54.3.145.
Anderson R, Atkinson A, Peacock JL, Marston L, Konstantinou K: Meta-Analysis of Time-Series and Panel Studies on Particulate Matter and Ozone (O3). 2004, Copenhagen, Denmark: Document EUR/04/5042688, WHO Task Group. WHO Regional Office for Europe
WHO: World Health Organization Regional Office for Europe Copenhagen. Air Quality Guidelines for Europe. 2000, WHO Regional Publications (European Series, No. 91), second
Gryparis A, Forsberg B, Katsouyanni K, Analitis A, Touloumi G, Schwartz J, Samoli E, Medina S, Anderson HR, Niciu EM, Wichmann HE, Kriz B, Kosnik M, Skorkovsky J, Vonk JM, Dortbudak Z: Acute effects of ozone on mortality from the “air pollution and health: a European approach” project. Am J Respir Crit Care Med. 2004, 170: 1080-1087. 10.1164/rccm.200403-333OC.
Samoli E, Aga E, Touloumi G, Nisiotis K, Forsberg B, Lefranc A, Pekkanen J, Wojtyniak B, Schindler C, Niciu E, Brunstein R, Dodic Fikfak M, Schwartz J, Katsouyanni K: Short-term effects of nitrogen dioxide on mortality: an analysis within the APHEA project. Eur Respir J. 2006, 27: 1129-1138. 10.1183/09031936.06.00143905.
WHO: Overview of the environment and health in Europe in the 1990s - Background document. 1999, World Health Organization Regional Publications, European Series, No 89
Burret RT, Doles RE: Association between ambient carbon monoxide levels and hospitalization for congestive heart failure in the elderly in 10 Canadian cities. Epidemiology. 1997, 8: 162-167. 10.1097/00001648-199703000-00007.
Spix C: Short-Term Effects of Air Pollution on Hospital Admissions of Respiratory Diseases in Europe: a quantitative summary of APHEA study results. Arch Enviro Health. 1997, 53: 54-64.
Touloumi G, Samoli E, Katsouyanni K: Daily mortality in “winter type” air pollution in Athens-a time-series analysis within the APHEA project. J Epidemiol Community Health. 1996, 50 (suppl 1): S47-S51. 10.1136/jech.50.Suppl_1.s47.
Anderson HR, Leon AP: Air pollution and daily mortality in London: 1987–92. BMJ. 1996, 312: 665-669. 10.1136/bmj.312.7032.665.
WHO: Air quality guidelines for particulate matter, ozone, nitrogen dioxide and sulfur dioxide: Summary of risk assessment, Global update 2005. 2005, World Health Organization, Available at: http://www.euro.who.int/Document/E87950.pdf
Boldo E, Medina S, LeTertre A, Hurley F, Mucke HG, Ballester F, Aguilera I, Eilstein D: Apheis: health impact assessment of long-term exposure to PM(2.5) in 23 European cities. Eur J Epidemiol. 2006, 21: 449-458. 10.1007/s10654-006-9014-0.
Tominz R, Mazzoleni B, Daris F: Estimate of potential health benefits of the reduction of air pollution with PM10 in Trieste, Italy. Epidemiol Prev. 2005, 29: 149-155.
Martuzzi M, Galassi C, Ostro B, Forastiere F, Bertollini R: Health Impact Assessment of Air Pollution in the Eight Major Italian Cities. 2002, WHO Europe EURO /02/5040650, Available at: http://www.euro.who.int/healthimpact
Martuzzi M, Mitis M, Iavarone I, Serinelli M: Health Impact of PM10 and Ozone in 13 Italian Cities. 2006, WHO Europe, Available at: http://www.euro.who.int/pubrequest
WHO: European Centre for Environment and Health. Quantification of the Health Effects of Exposure to Air Pollution. 2000, Bilthoven, Netherlands: Report of a WHO Working Group, EUR/01/5026342